Candida Vulvovaginitis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-09-08
Clinical Trial Update: Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis [Phase 3]
Phase 3 trial evaluating oral ibrexnafungerp (SCY-078) versus placebo for acute vulvovaginal candidiasis completed with posted results.